Tsuyoshi Horikawa

SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation

Shiho Komatsu, Takashi Nomiyama, Tomohiro Numata et al. · Endocrine Journal · 2019 · 88 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation

Chikayo Iwaya, Takashi Nomiyama, Shiho Komatsu et al. · Endocrinology · 2017 · 83 citations · Full text

Life Sciences, Endocrinology, Oncology +17

Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study

Taku Obara, Takayoshi Ohkubo, Masahiro Kikuya et al. · Blood Pressure Monitoring · 2005 · 57 citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +15

Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro

Leona Yamamoto, Shin-ichi Yamashita, Takashi Nomiyama et al. · Diabetology International · 2021 · 45 citations · Full text

Medicine, Oncology, Pharmacology +10

Activation of overexpressed glucagon‐like peptide‐1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression

Toru Shigeoka, Takashi Nomiyama, Takako Kawanami et al. · Journal of Diabetes Investigation · 2020 · 44 citations · Full text

Life Sciences, Endocrinology, Pharmacology +16